NHS Lanarkshire’s covid-19 vaccination programme has been continuing at speed and we have now offered appointments to everyone aged over 50 and those with underlying health conditions who are under 50.

 

Dr Mark Russell, Lead for the covid-19 vaccination programme in Lanarkshire, said: “We have made great progress in our vaccination programme and it means we have completed up to priority group 9 ahead of schedule. We would not have been able to vaccinate at such a pace without our supercentres. This means that 58% of the local adult population has received their first dose.

 

“Before we move onto priority group 10 (40 to 49 year olds) and second doses, we will be vaccinating people who have chosen to reschedule their appointment to a local centre. Over the Easter weekend our supercentres will close, to allow staff to move to local centres and complete these mop-up vaccinations.”

 

As we move onto second doses people aged over 80 will receive theirs from their GP practice, the same as their first dose. People who are housebound, will continue to receive a home visit.

 

For people aged 70 to 79 second dose appointments will be at their nearest vaccination clinic. This could be at a local centres or supercentre, depending on which is nearest.

 

Dr Russell added: “I would like to thank everyone who has attended for their vaccination appointment, which is helping to return us to normal life faster. It is important that we all attend for our vaccination and our second dose when we are invited. It’s the most important journey that any of us will make this year.”

 

Once you’ve been vaccinated, it is still important to stick to the FACTS guidance and follow national guidance.

 

More information on the local vaccination programme is available at www.nhslanarkshire.scot.nhs.uk/covid-19-vaccine This includes dates for local centres and transport information.

Healthcare Professional ONLY
This website is intended for Healthcare professionals only

Are you a qualified pharmacist or health professional?
By continuing to access this site, you are consenting to viewing promotional product information provided by our pharmaceutical company sponsors